Biodistribution of iodine-125 tyramine transforming growth factor alpha antisense oligonucleotide in athymic mice with a human mammary tumour xenograft following intratumoral injection

European Journal of Nuclear Medicine
S CammilleriH Magdelenat

Abstract

The Watson-Crick base pairing rule provides the underlying principle for the antisense (AS) approach to inhibiting gene expression. Transforming growth factor alpha (TGFalpha) was the first growth factor to be associated with tumorigenesis, thus making the TGFalpha (mRNA) a potential target for AS therapy and offering the potential for monitoring of the progression of malignancy by non-invasive imaging with radiolabelled AS phosphodiester. Probe labelling and biodistribution were studied in the present report. A 23-mer oligonucleotide sequence was synthesized and grafted in 5' with a tyramine group which was further radioiodinated. The radiolabelled AS was injected intratumorally in mammary tumour-bearing BALB/c mice (3 weeks after inoculation of 7.10(6)NS2T2A mammary cells). Biodistribution was monitored by sequential scintigraphy and organ radioactivity after autopsy. The 5' tyramine group allowed specific and stable radiolabelling of the AS with 125I. The 125I AS oligonucleotide was rapidly cleared from the tumour by intestine and kidneys. Four hours after intratumoral injection, 6.5%+/-1.5% of the dose was retained in the tumour as non-degraded 125I AS. It is concluded that 5' tyraminylated AS provides information on the bi...Continue Reading

References

Jan 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·P C Zamecnik, M L Stephenson
Nov 1, 1992·In Vitro Cellular & Developmental Biology : Journal of the Tissue Culture Association·P BerthonF Calvo
Aug 19, 1992·International Journal of Cancer. Journal International Du Cancer·P BerthonF Calvo
Jan 1, 1992·Antisense Research and Development·S Agrawal, J Y Tang
Jun 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·P C ZamecnikP S Sarin
Feb 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·E L WickstromE Wickstrom
Sep 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·G J TodaroJ E De Larco
Jun 1, 1995·European Journal of Nuclear Medicine·J L UrbainE P Reddy

❮ Previous
Next ❯

Citations

Jan 29, 2003·Journal of Cellular Biochemistry. Supplement·Uwe Haberkorn, Annette Altmann
Aug 10, 2006·European Journal of Nuclear Medicine and Molecular Imaging·Franz BucheggerAngelika Bischof Delaloye
Oct 22, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Ronald Blasberg
May 18, 1999·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·S S GambhirM E Phelps
Apr 18, 1998·Nature Medicine·B TavitianL Di Giamberardino
Oct 19, 2001·Nuclear Medicine Communications·M A Stalteri, S J Mather
Sep 12, 2002·Expert Opinion on Therapeutic Targets·Ding Cheng YangJonathan F Head
Dec 24, 2014·Nucleic Acid Therapeutics·Katherine PerschbacherL James Maher
Jan 22, 2004·Seminars in Nuclear Medicine·Uwe HaberkornMichael Eisenhut
Oct 3, 2003·Journal of Cellular Biochemistry·Michael R Lewis, Fang Jia
Oct 9, 2002·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Ronald Blasberg
Oct 24, 2003·Annals of Medicine·Uwe Haberkorn, Annette Altmann
Nov 23, 2006·Hematology/oncology Clinics of North America·Inna Serganova, Ronald G Blasberg
Mar 7, 2009·European Journal of Radiology·Archana MukherjeeMathew L Thakur

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
S L LokeL M Neckers
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
J Giannios, P Ginopoulos
© 2021 Meta ULC. All rights reserved